Arda Therapeutics, Inc. — Form D
Arda Therapeutics, Inc. of San Carlos, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-14. The offering totals $8.5M, of which $7.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-01-14
- Form: D
- Accession: 0001903317-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.5M
- Amount sold: $7.5M
- Remaining: $1000K
- Investors: 10
- Date of first sale: 2021-12-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-429582
Issuer
- Name: Arda Therapeutics, Inc.
- CIK: 0001903317
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 930 Brittan Ave, San Carlos, CA, 94070
- Phone: (650) 804-8953
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Vineeta Agarwala | Director | Menlo Park, CA |
| Adam Freund | Director | San Carlos, CA |
| Adam Freund | Executive Officer | San Carlos, CA |
Other filings by this issuer (1)
More